What Is The Cost Of Not Doing MES?
“If you need to do an ROI study, then perhaps MES is not for you ...!” goes a provocative comment from a consultant when positioning to management the benefits of Manufacturing Execution Systems (MES). In this age of digitization, many pharma and biotech companies still struggle to gain senior level buy-in for investments in manufacturing IT. Whilst corporate IT initiatives such as Enterprise Resource Planning (ERP) are well understood and seen as ‘nobrainers’, not believing in a Return On Investment (ROI) for manufacturing solutions is a major reason why companies still struggle to eliminate paper GxP records and modernize systems.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.